These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33253485)

  • 1. Performance of the currently available DIVA real-time PCR assays in classical and recombinant lumpy skin disease viruses.
    Byadovskaya O; Pestova Y; Kononov A; Shumilova I; Kononova S; Nesterov A; Babiuk S; Sprygin A
    Transbound Emerg Dis; 2021 Nov; 68(6):3020-3024. PubMed ID: 33253485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains.
    Haegeman A; De Leeuw I; Philips W; De Regge N
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a TaqMan probe-based real-time PCR method for the differentiation of wild type lumpy skin disease virus from vaccine virus strains.
    Agianniotaki EI; Chaintoutis SC; Haegeman A; Tasioudi KE; De Leeuw I; Katsoulos PD; Sachpatzidis A; De Clercq K; Alexandropoulos T; Polizopoulou ZS; Chondrokouki ED; Dovas CI
    J Virol Methods; 2017 Nov; 249():48-57. PubMed ID: 28837841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumpy skin disease outbreaks in Greece during 2015-16, implementation of emergency immunization and genetic differentiation between field isolates and vaccine virus strains.
    Agianniotaki EI; Tasioudi KE; Chaintoutis SC; Iliadou P; Mangana-Vougiouka O; Kirtzalidou A; Alexandropoulos T; Sachpatzidis A; Plevraki E; Dovas CI; Chondrokouki E
    Vet Microbiol; 2017 Mar; 201():78-84. PubMed ID: 28284627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TaqMan probe-based multiplex real-time PCR method for the specific detection of wild type lumpy skin disease virus with beta-actin as internal amplification control.
    Agianniotaki EI; Chaintoutis SC; Haegeman A; De Clercq K; Chondrokouki E; Dovas CI
    Mol Cell Probes; 2021 Dec; 60():101778. PubMed ID: 34774743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease.
    Katsoulos PD; Chaintoutis SC; Dovas CI; Polizopoulou ZS; Brellou GD; Agianniotaki EI; Tasioudi KE; Chondrokouki E; Papadopoulos O; Karatzias H; Boscos C
    Transbound Emerg Dis; 2018 Feb; 65(1):174-185. PubMed ID: 28391652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study.
    Ben-Gera J; Klement E; Khinich E; Stram Y; Shpigel NY
    Vaccine; 2015 Sep; 33(38):4837-42. PubMed ID: 26238726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.
    Gari G; Abie G; Gizaw D; Wubete A; Kidane M; Asgedom H; Bayissa B; Ayelet G; Oura CA; Roger F; Tuppurainen ES
    Vaccine; 2015 Jun; 33(28):3256-61. PubMed ID: 26056063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of recombination of vaccine strains of lumpy skin disease virus with field strains, causing disease.
    Sprygin A; Pestova Y; Bjadovskaya O; Prutnikov P; Zinyakov N; Kononova S; Ruchnova O; Lozovoy D; Chvala I; Kononov A
    PLoS One; 2020; 15(5):e0232584. PubMed ID: 32401805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSDV126 gene based molecular assays for specific detection and characterization of emerging Lumpy Skin Disease virus.
    Nandi S; Mahajan S; Mishra R; Nautiyal S; Agrawal RK; Singh M; Biswas SK; Chander V; Singh KP; Sharma GK
    J Virol Methods; 2023 Feb; 312():114665. PubMed ID: 36509247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental lumpy skin disease virus infection of cattle: comparison of a field strain and a vaccine strain.
    Möller J; Moritz T; Schlottau K; Krstevski K; Hoffmann D; Beer M; Hoffmann B
    Arch Virol; 2019 Dec; 164(12):2931-2941. PubMed ID: 31538254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A real-time PCR screening assay for the universal detection of lumpy skin disease virus DNA.
    Alexander S; Olga B; Svetlana K; Valeriy Z; Yana P; Pavel P; Aleksandr K
    BMC Res Notes; 2019 Jul; 12(1):371. PubMed ID: 31262345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-resolution melting (HRM) assay for the differentiation between Israeli field and Neethling vaccine lumpy skin disease viruses.
    Menasherow S; Erster O; Rubinstein-Giuni M; Kovtunenko A; Eyngor E; Gelman B; Khinich E; Stram Y
    J Virol Methods; 2016 Jun; 232():12-5. PubMed ID: 26902159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HRM-based gap-qRT-PCR for identification and quantitation of the vaccine and field strain(s) of lumpy skin disease virus.
    Kumar R; Chander Y; Verma A; Tripathi BN; Barua S; Kumar N
    J Immunol Methods; 2023 Aug; 519():113521. PubMed ID: 37392930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of putative immunomodulatory gene knockouts of lumpy skin disease virus in cattle towards an improved vaccine.
    Kara PD; Mather AS; Pretorius A; Chetty T; Babiuk S; Wallace DB
    Vaccine; 2018 Jul; 36(31):4708-4715. PubMed ID: 29941325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency vaccination of cattle against lumpy skin disease: Evaluation of safety, efficacy, and potency of MEVAC
    Bazid AH; Wasfy M; Fawzy M; Nayel M; Abdelmegeid M; Thabet RY; Yong HS; El-Sayed MM; Magouz A; Badr Y
    Vet Res Commun; 2023 Jun; 47(2):767-777. PubMed ID: 36460903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vaccine-like lumpy skin disease virus from flies near the western border of China.
    Wang Y; Zhao L; Yang J; Shi M; Nie F; Liu S; Wang Z; Huang D; Wu H; Li D; Lin H; Li Y
    Transbound Emerg Dis; 2022 Jul; 69(4):1813-1823. PubMed ID: 34033246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenomic characterization of historic lumpy skin disease virus isolates from South Africa.
    van Schalkwyk A; Kara P; Heath L
    Arch Virol; 2022 Oct; 167(10):2063-2070. PubMed ID: 35792935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India.
    Kumar N; Barua S; Kumar R; Khandelwal N; Kumar A; Verma A; Singh L; Godara B; Chander Y; Kumar G; Riyesh T; Sharma DK; Pathak A; Kumar S; Dedar RK; Mehta V; Gaur M; Bhardwaj B; Vyas V; Chaudhary S; Yadav V; Bhati A; Kaul R; Bashir A; Andrabi A; Yousuf RW; Koul A; Kachhawaha S; Gurav A; Gautam S; Tiwari HA; Munjal VK; Gupta MK; Kumar R; Gulati BR; Misri J; Kumar A; Mohanty AK; Nandi S; Singh KP; Pal Y; Dutt T; Tripathi BN
    Virulence; 2023 Dec; 14(1):2190647. PubMed ID: 36919498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.